TrialFrontiers in immunology2024

Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod.

Mohamed Abdel-Mohsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.